Table 4.
Formulation | Cell viability of CPT-DNA-NT (%) | Cell viability of free CPT equimolar (%) |
---|---|---|
C1 | 96.42 | 98.19 |
C2 | 89.10 | 96.07 |
C3 | 85.07 | 89.13 |
C4 | 76.12 | 83.97 |
C5 | 72.01 | 79.91 |
C6 | 64.38 | 71.09 |
C7 | 53.89 | 62.01 |
C8 | 38.61 | 47.82 |
Formulation | Cell viability of CPT-DNA-NT (%) | Cell viability of free CPT equimolar (%) |
---|---|---|
C1 | 96.42 | 98.19 |
C2 | 89.10 | 96.07 |
C3 | 85.07 | 89.13 |
C4 | 76.12 | 83.97 |
C5 | 72.01 | 79.91 |
C6 | 64.38 | 71.09 |
C7 | 53.89 | 62.01 |
C8 | 38.61 | 47.82 |